Calcium Signaling Is Impaired in PTEN-Deficient T Cell Acute Lymphoblastic Leukemia

Saran Pankaew1,2, Delphine Potier1, Clémence Grosjean1

  • 1Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.

Frontiers in Immunology
|February 21, 2022
PubMed

Insights

PTEN loss in T-ALL impairs calcium signaling by reducing inositol trisphosphate receptors (ITPRs). This defect is crucial for T-cell acute lymphoblastic leukemia development, highlighting PTEN

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • PTEN is a critical tumor suppressor gene implicated in various cancers, including T-cell acute lymphoblastic leukemia (T-ALL).
  • Loss-of-function mutations in PTEN are associated with mature T-ALL expressing T-cell receptors (TCRs).
  • Pten inactivation in mouse thymocytes recapitulates human T-ALL, leading to TCRαβ+ T-ALL.

Purpose of the Study:

  • To investigate the functional interplay between TCR signaling and PTEN in T-ALL pathogenesis.
  • To elucidate the role of PTEN in regulating calcium flux and its downstream effectors in thymocytes.
  • To identify potential therapeutic targets by understanding the PTEN-TCR-calcium signaling axis.

Main Methods:

  • Single-cell RNA sequencing (scRNAseq) of PTEN-deficient and PTEN-proficient thymocytes.
  • Bioinformatic analysis to infer pathway activity, focusing on calcium signaling.
  • Ex vivo calcium flux assays to measure intracellular calcium ion (Ca2+) release.
  • Mathematical modeling of calcium flux mechanisms integrating TCR signaling and PTEN interactions.
  • Analysis of inositol 1,4,5-trisphosphate receptor (ITPR) expression at the mRNA and protein levels.

Main Results:

  • PTEN-deficient thymocytes exhibited reduced Myc transcript levels and significantly lower calcium pathway activity compared to PTEN-proficient cells.
  • Ex vivo assays confirmed that PTEN-deficient T-ALL cells are unable to release Ca2+ from the endoplasmic reticulum upon TCR activation.
  • Mathematical modeling predicted a positive regulatory role of PTEN on ITPR activity.
  • Reduced ITPR protein levels were observed in PTEN-deficient T-ALL cells, correlating with impaired calcium flux.
  • Normal calcium flux and ITPR expression in non-leukemic PTEN-deficient T cells suggest that additional alterations are necessary for T-ALL development.

Conclusions:

  • PTEN loss contributes to T-ALL oncogenesis by disrupting the ITPR/calcium flux pathway.
  • PTEN positively regulates ITPR expression/function in thymocytes, impacting calcium homeostasis.
  • Impaired calcium signaling due to PTEN deficiency is a key feature of T-ALL, but requires cooperating events for leukemogenesis.
  • PTEN's role in regulating ITPR protein levels in thymocytes warrants further investigation.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.5K
Microtubules in Signaling01:22

Microtubules in Signaling

The primary cilium, made up of microtubules, acts as antennae on the cell surfaces for relaying external stimuli into the cells. These fine hair-like structures are present, generally one per cell. These are non-motile cilia in a 9+0 microtubules arrangement, where the central pair of microtubules are absent. The primary cilia arise from the basal body embedded in the cell membrane. Intraflagellar transport (IFT) carries requisite proteins from the cytoplasm to the cilium because the primary...
1.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K